Nektar Therapeutics (NKTR) Q3 2019 Earnings Report
MX:NKTR Q3 2019 EPS Results
- Actual EPS
- -MXN 10.52
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -MXN 10.52
MX:NKTR Q3 2019 Revenue Results
- Actual Revenue
- MXN 548.89M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +5.24%
Earnings Announcement Details
- Quarter
- Q3 2019
- Date
- 11/06/2019
- Time
- After Close
- Conference Call
- Wednesday, November 6, 2019
MX:NKTR Upcoming Earnings
Nektar Therapeutics's next earnings date is estimated for November 12, 2026, based on past reporting schedules.
Q3 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:NKTR Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 12, 2026 | 2026 (Q3) | -38.87- | -35.13 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | -37.03-23.11 | -55.42 | 58.31% (+32.31) | |
| May 07, 2026 | 2026 (Q1) | -29.72-34.19 | -67.63 | 49.44% (+33.44) | |
| Mar 12, 2026 | 2025 (Q4) | -46.48-33.44 | 8.45 | -495.56% (-41.89) | |
| Nov 06, 2025 | 2025 (Q3) | -50.44-35.13 | -50.72 | 30.74% (+15.59) | |
| Aug 07, 2025 | 2025 (Q2) | -56.88-55.42 | -70.45 | 21.33% (+15.03) | |
| May 08, 2025 | 2025 (Q1) | -48.17-67.63 | -53.54 | -26.32% (-14.09) | |
| Mar 12, 2025 | 2024 (Q4) | -38.218.45 | -61.99 | 113.64% (+70.45) | |
| Nov 07, 2024 | 2024 (Q3) | -56.08-50.72 | -67.63 | 25.00% (+16.91) | |
| Aug 08, 2024 | 2024 (Q2) | -52.13-70.45 | -76.08 | 7.41% (+5.64) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed